Ghaziabad, Uttar Pradesh, India
Verified
Add Review
Our Products
IgE Rapid Test Kit (Whole Blood/Serum /Plasma): IgE Rapid Test qualitatively detects human IgE antibodies in human whole blood, serum, and plasma. The test is intended for professional use to help diagnose allergies.ImmunoCHECK IgE Rapid Test is a qualitative, lateral flow immunoassay for the detection of human IgE antibody in whole blood, serum or plasma specimens. In this test, mouse antihuman IgE is coated in the test line region of the test.
During testing, IgE present in whole blood, serum or plasma specimens reacts with mouse anti-human IgE-coated particles in the test strip.
The Fetal Fibronectin Rapid Test (FFN) is a diagnostic tool used to assess the risk of preterm birth in pregnant women. It detects the presence of fetal fibronectin, a protein that acts as "glue" attaching the fetal sac to the uterine lining. Normally, fetal fibronectin is present during early pregnancy and then decreases as the pregnancy progresses.
The Menopause (FSH) Rapid Test is a diagnostic tool used to determine a woman's menopausal status by measuring the level of follicle-stimulating hormone (FSH) in her blood. FSH is a hormone produced by the pituitary gland that helps regulate the menstrual cycle and stimulates the ovaries to produce eggs.
The Vaginal pH Test Kit is a diagnostic tool used to measure the acidity or alkalinity of the vaginal environment. Vaginal pH is an important indicator of vaginal health and can help diagnose various vaginal infections and conditions.
A normal vaginal pH is typically acidic, ranging from around 3.8 to 4.5. However, certain conditions such as bacterial vaginosis, trichomoniasis, and yeast infections can cause the vaginal pH to become more alkaline (higher pH).
The Alpha Fetoprotein (AFP) Rapid Test is a diagnostic tool used to measure the level of alpha-fetoprotein in the blood. Alpha-fetoprotein is a protein produced by the liver and yolk sac of a developing fetus, and its levels can be indicative of certain conditions in both pregnant and non-pregnant individuals.
In pregnant women, AFP levels can be used as a screening tool for certain fetal abnormalities, particularly neural tube defects such as spina bifida and anencephaly. Abnormal levels of AFP may also indicate other fetal conditions, such as abdominal wall defects or chromosomal abnormalities.
In non-pregnant individuals, elevated AFP levels can be associated with certain liver conditions, such as hepatocellular carcinoma (liver cancer) or cirrhosis. However, it's important to note that AFP levels can also be elevated in non-cancerous liver diseases and during pregnancy.
The AFP Rapid Test typically involves a blood sample collection and provides quick results, often within minutes. Healthcare providers use these results, along with other clinical information, to make diagnostic and management decisions for their patients.
The Carcinoembryonic Antigen (CEA) Rapid Test is a diagnostic tool used to measure the level of carcinoembryonic antigen in the blood. CEA is a protein that is normally produced in very low levels by fetal tissue during development, but it can also be produced by certain types of cancerous tumors, particularly those in the colon, rectum, pancreas, stomach, and breast.
The CEA Rapid Test is primarily used as a tumor marker to help in the diagnosis, monitoring, and management of cancer. It is particularly useful in assessing colorectal cancer, where elevated levels of CEA may indicate the presence of the disease, as well as in monitoring the effectiveness of treatment and detecting any recurrence.
The test typically involves collecting a blood sample, and the results can be obtained rapidly, often within minutes. Healthcare providers use the results, along with other clinical information, to guide treatment decisions and monitor the progression of the disease.
It's important to note that while elevated CEA levels can indicate the presence of cancer, they can also be elevated in non-cancerous conditions such as inflammation, infection, or certain other medical conditions. Therefore, further evaluation is often necessary to determine the underlying cause of elevated CEA levels.
The Fecal Occult Blood Rapid Test is a diagnostic tool used to detect hidden (occult) blood in the stool. Occult blood in the stool can be a sign of various gastrointestinal conditions, including colorectal cancer, polyps, inflammatory bowel disease, or other bleeding disorders.
This test is often used as a screening tool for colorectal cancer and other gastrointestinal conditions, especially in individuals who may not have visible symptoms. Detecting occult blood early can lead to timely intervention and treatment, potentially improving outcomes.However, it's important to note that a positive result from the Fecal Occult Blood Rapid Test does not necessarily mean the presence of cancer; it requires further investigation, usually with follow-up diagnostic tests such as colonoscopy or sigmoidoscopy, to confirm the cause of the bleeding.Overall, the Fecal Occult Blood Rapid Test is a valuable tool in the early detection and management of gastrointestinal conditions, helping to improve patient outcomes through early intervention.
The Fecal Occult Blood/Transferrin Combo Rapid Test is a diagnostic tool used to detect both occult blood and transferrin in the stool. Transferrin is a protein found in blood plasma that can be elevated in the presence of gastrointestinal bleeding.
This combination test is particularly useful for screening for colorectal cancer and other gastrointestinal conditions, as it can detect both blood and transferrin in the stool, providing a more comprehensive assessment of gastrointestinal health.
The PSA Rapid Test is a diagnostic tool used to measure the level of prostate-specific antigen (PSA) in the blood. PSA is a protein produced by the prostate gland, and elevated levels can be indicative of prostate cancer or other prostate-related conditions.
The PSA Rapid Test is primarily used for screening and monitoring prostate cancer. It involves collecting a small blood sample, typically through a finger prick or venous blood draw. The sample is then applied to a test device, and the presence of PSA is detected within a short period, often within minutes.
The TF (Transferrin) Rapid Test is a diagnostic tool used to measure the level of transferrin in the blood. Transferrin is a protein responsible for transporting iron in the body and is primarily produced by the liver.
This rapid test is used to assess transferrin levels quickly, often within minutes, by analyzing a small blood sample. Abnormal levels of transferrin can indicate various conditions such as iron deficiency anemia, liver disease, or protein malnutrition.
The TF Rapid Test is particularly useful in diagnosing iron deficiency anemia, where low levels of transferrin may suggest insufficient iron transport in the body. Additionally, abnormal transferrin levels can also indicate liver dysfunction, as the liver is the primary site of transferrin production.
The CK-MB rapid test is a diagnostic tool used to measure the levels of creatine kinase MB (CK-MB) in the blood. CK-MB is an enzyme found primarily in the heart muscle. Elevated levels of CK-MB can indicate damage to the heart, such as a heart attack or myocardial infarction.
The rapid test typically involves collecting a small sample of blood from the patient, usually through a finger prick or venipuncture. The sample is then applied to the test device, which contains specific antibodies that react with CK-MB if present in the blood.
The myoglobin rapid test is a diagnostic tool used to measure the levels of myoglobin in the blood. Myoglobin is a protein found in muscle tissues, including the heart and skeletal muscles. Elevated levels of myoglobin in the blood can indicate muscle damage or injury, including heart damage such as a heart attack.
Similar to the CK-MB rapid test, the myoglobin rapid test involves collecting a small sample of blood from the patient, typically through a finger prick or venipuncture. The sample is then applied to the test device, which contains specific antibodies that react with myoglobin if present in the blood.
NT-proBNP, or N-terminal pro-brain natriuretic peptide, is a biomarker used in medicine to assess heart function. It is a precursor molecule to B-type natriuretic peptide (BNP), which is released by the heart in response to increased pressure and volume overload, particularly in conditions like heart failure.
The NT-proBNP test measures the levels of this peptide in the blood. Higher levels of NT-proBNP typically indicate greater stress on the heart, which can be due to conditions such as heart failure, myocardial infarction, or pulmonary hypertension.
The adenovirus antigen rapid test is a diagnostic tool used to detect the presence of adenovirus antigens in a patient's sample, typically from respiratory secretions such as nasopharyngeal swabs or throat swabs. Adenoviruses are a common cause of respiratory infections, conjunctivitis, and other illnesses.
This rapid test works by detecting specific proteins (antigens) on the surface of adenovirus particles. A positive result indicates the presence of adenovirus antigens in the sample, suggesting an active adenovirus infection.
The test procedure usually involves collecting a sample from the patient's respiratory tract and applying it to the test device. The device contains antibodies that react with adenovirus antigens, producing a visible result within a short period, typically within 15-20 minutes.
The adenovirus antigen rapid test is valuable for quickly identifying adenovirus infections, especially in settings like clinics, hospitals, or during outbreaks. It aids in prompt diagnosis and appropriate management of patients with respiratory symptoms, enabling timely treatment and infection control measures. However, as with any diagnostic test, it's essential to interpret the results in conjunction with clinical symptoms and other diagnostic tests if necessary.
The Brucellosis IgG/IgM rapid test is a diagnostic tool used to detect antibodies against Brucella bacteria in a patient's blood serum. Brucellosis is a bacterial infection transmitted to humans through contact with infected animals or consumption of contaminated animal products.
The test detects two types of antibodies produced by the immune system in response to Brucella infection: immunoglobulin G (IgG) and immunoglobulin M (IgM). IgM antibodies are typically produced early in the course of infection, while IgG antibodies develop later and persist for a longer period.
To perform the test, a small blood sample is collected from the patient, usually via a finger prick or venipuncture. The sample is then applied to the test device, which contains antigens specific to Brucella bacteria. If the patient's blood contains Brucella antibodies (either IgG or IgM), they will bind to the antigens on the test device, producing a visible result within a short period, usually around 10-15 minutes.
A positive result on the Brucellosis IgG/IgM rapid test indicates the presence of Brucella antibodies in the blood, suggesting a current or recent infection with the bacteria. Further diagnostic tests and clinical evaluation may be needed to confirm the diagnosis and determine the appropriate treatment.
This rapid test is particularly useful in regions where brucellosis is endemic or in outbreak situations, allowing for quick identification of infected individuals and timely implementation of control measures. However, as with any diagnostic test, interpretation should consider clinical symptoms and other relevant factors.
The Human Chorionic Gonadotropin (hCG) Rapid Test Device is a medical diagnostic tool used to detect the presence of hCG in a patient's urine or serum. hCG is a hormone produced by the placenta during pregnancy, and its detection in a woman's body is an indication of pregnancy. The hCG Rapid Test Device is designed to provide a quick and convenient way to determine whether a woman is pregnant.
The "Malaria Rapid Pf/Pv Test" is a diagnostic tool designed for the qualitative detection of Plasmodium falciparum (Pf) and Plasmodium vivax (Pv) antigens, which are the causative agents of malaria caused by these two specific malaria parasite species. This test plays a vital role in the diagnosis and management of malaria cases, particularly in regions where these parasites are prevalent.
The Dengue NS1 (Non-Structural Protein 1) Antigen Test Kit is a diagnostic tool used to detect the presence of the dengue NS1 antigen in a patient's blood. This test helps in the early diagnosis of dengue fever, a mosquito-borne viral infection caused by various serotypes of the dengue virus. Detection of NS1 antigen is particularly valuable during the early stages of dengue infection when viral RNA or antibodies may not yet be detectable.
The Dengue IgG/IgM Antibody Combo Test Kit is a diagnostic tool used to detect the presence of both IgG (Immunoglobulin G) and IgM (Immunoglobulin M) antibodies specific to the dengue virus in a patient's blood. This test helps in the diagnosis of dengue fever, a mosquito-borne viral infection caused by various serotypes of the dengue virus.
A Vitamin D Rapid Test is a diagnostic tool used to measure the concentration of vitamin D in a patient's blood. Vitamin D is essential for maintaining strong bones, a healthy immune system, and other vital functions in the body. This test helps in assessing a person's vitamin D status and determining whether they have a deficiency or sufficiency of this important nutrient.
The Typhoid IgG/IgM Rapid Test Kit is a diagnostic tool used for the rapid detection of antibodies specific to the bacterium Salmonella Typhi, which causes typhoid fever. This test helps in the diagnosis of typhoid infections by detecting the presence of IgG and IgM antibodies in a patient's blood.
Troponin I (TnI) is a critical biomarker used in medical diagnostics, specifically for assessing cardiac health and diagnosing heart-related conditions. It is a protein found primarily in cardiac muscle tissue and is released into the bloodstream when heart muscle cells (cardiomyocytes) are damaged or injured, such as during a heart attack (myocardial infarction).
An HbsAg (Hepatitis B surface antigen) device typically refers to a diagnostic test device or assay used to detect the presence of the hepatitis B surface antigen in a patient's blood or serum. Hepatitis B is a viral infection that primarily affects the liver and can lead to chronic liver disease if left untreated. Diagnostic devices for hepatitis B are used to screen individuals for the presence of the virus or to confirm previous exposure to the virus.
An HCV (Hepatitis C Virus) device typically refers to a diagnostic test device or assay used to detect the presence of hepatitis C virus in a patient's blood or serum. Hepatitis C is a viral infection that primarily affects the liver and can lead to chronic liver disease if left untreated. Diagnostic devices for hepatitis C are used to screen individuals for the presence of the virus, which can then be confirmed through more specific laboratory tests.
antigen (H.Pylori Ag) is a substance produced by the bacterium Helicobacter pylori. H. pylori is a type of bacteria that infects the stomach lining and can cause various gastrointestinal problems, including gastritis and peptic ulcers. Testing for the presence of H. pylori antigen in the body, typically through a stool sample or a breath test, is a common method used to diagnose H. pylori infection. This antigen test helps in identifying the presence of the bacterium and guides healthcare providers in determining appropriate treatment strategies, such as antibiotics and proton pump inhibitors, to eradicate the infection and manage associated symptoms.
A Scrub Typhus Test Kit is a diagnostic tool used to detect antibodies or antigens associated with the bacterium Orientia tsutsugamushi, which causes scrub typhus. Scrub typhus is a tropical disease transmitted to humans through the bite of infected chiggers (tiny mites found in rural and forested areas). It can lead to a range of symptoms, from mild to severe, and is a significant health concern in certain regions. The Scrub Typhus Test Kit helps in the diagnosis of scrub typhus by detecting specific antibodies or antigens in a patient's blood or serum.
The Rapid Plasma Reagin (RPR) test is a screening test for syphilis. It detects antibodies in the blood that are produced by the body in response to the bacterium Treponema pallidum, which causes syphilis. The RPR test is typically performed using a slide coated with a substance containing cardiolipin, cholesterol, and lecithin, along with a carbon particle suspension. When the test serum is mixed with the reagent on the slide, if antibodies against Treponema pallidum are present, they will react with the cardiolipin-cholesterol-lecithin antigen, causing visible clumping or agglutination.
An RPR card is a diagnostic tool used for the Rapid Plasma Reagin (RPR) test. It typically consists of a small card with wells or circles where the test samples are placed. The card is coated with a substance containing cardiolipin, cholesterol, and lecithin, along with a carbon particle suspension. When a sample (usually serum or plasma) containing antibodies to Treponema pallidum, the bacterium that causes syphilis, is applied to the card, it interacts with the reagents on the card. If antibodies are present, they will cause visible clumping or agglutination, indicating a positive result.
InfectoDx is a rapid, point-of-care diagnostic test that is designed to aid in the differentiation of bacterial and viral/acute respiratory infections (ARIs), thus helping to guide decisions regarding the prescription of antibiotics in the outpatient setting. It is used in patients More than 2 years old with viral/bacterial infection symptoms consistent with a community-acquired ARI.
The test is simple, requires no additional equipment and produces actionable results in 10 minutes. InfectoDx results can help guide (improve) antibiotic prescribing decisions. Reducing the unnecessary or inappropriate prescription of antibiotics for ARIs of probable viral aetiology is important for antibiotic stewardship and can also reduce the unnecessary exposure of patients to the risk of antibiotic-related adverse events. InfectoDx thus represents a useful diagnostic tool in the outpatient setting.
